SS Innovations CEO performs surgery about 7,500 miles away
The Barcelona demonstration connected a surgeon to a patient in Bengaluru approximately 7,500 miles away, while four separate telesurgeries were performed in New Delhi.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SS Innovations International, Inc. (SSII) said its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were showcased in successful telesurgeries in October 2026 at the EACTS Annual Meeting in Barcelona and the Society of Robotic Surgery India Conference in New Delhi. At EACTS, Chairman and CEO Dr. Sudhir Srivastava performed a robotic atrial septal defect procedure from Barcelona, approximately 7,500 miles (12,000 kilometers) from the patient in Bengaluru; Dr. Lalit Malik, Chief Cardiac Surgeon of Manipal Hospital Jaipur, provided patient-side support.
At SRS India, four surgeons completed four separate telesurgeries: a right partial nephrectomy, right hemicolectomy, left-sided pyeloplasty on a pediatric patient, and modified radical hysterectomy with sentinel lymph node biopsy. SS Innovations said 205 telesurgeries, including intricate cardiac procedures, had been performed with the SSi Mantra as of October 23, 2026.
8-K Event Classification
Key Figures
Key Terms
atrial septal defect (ASD) medical
partial nephrectomy medical
pyeloplasty medical
sentinel lymph node biopsy medical
ultra-low latency connectivity technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What procedures were demonstrated at SSII's SRS India Conference?
How many telesurgeries had SSII performed by October 23, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including
area code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
As used in this Current Report on Form 8-K (this “Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.
Item 8.01 Other Events.
On October 26, 2026, SSi issued a press release announcing that the Company’s SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain and the Society of Robotic Surgery India (“SRS India”) Conference in New Delhi, India.
A copy of the press release is included as Exhibit 99.1 to this Current Report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | Press Release, dated October 26, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: October 26, 2026 | SS INNOVATIONS INTERNATIONAL, INC. | |
| By: | /s/ Sudhir Srivastava | |
| Sudhir Srivastava, M.D. | ||
| Chairman and Chief Executive Officer | ||
2
Exhibit 99.1
SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences
FORT LAUDERDALE, Fla. – October 26, 2026 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain and the Society of Robotic Surgery India (“SRS India”) Conference in New Delhi, India.
| At the EACTS Annual Meeting, the Company’s Chairman of the Board and Chief Executive Officer, Dr. Sudhir Srivastava, successfully performed a robotic-assisted cardiac telesurgery utilizing the SSi Mantra and SSi MantrAsana tele-surgeon console live on stage in Barcelona, approximately 7,500 miles (12,000 kilometers) from the patient at Sri Madhusudan Sai Institute of Medical Sciences and Research in Bengaluru, India. Dr. Srivastava remotely performed a robotic atrial septal defect (ASD) procedure with patient-side support from Dr. Lalit Malik, Chief Cardiac Surgeon of Manipal Hospital Jaipur. The EACTS Annual Meeting is the largest global gathering of leaders in the cardiothoracic surgical community, bringing together thousands of industry professionals each year. |  | |
| (Dr. Srivastava conducting a live long-distance telesurgery at the EACTS Annual Meeting, utilizing the SSi MantrAsana tele-surgeon console.) |
At the inaugural SRS India Conference, four surgeons successfully completed four separate robotic-assisted telesurgeries featuring the SSi Mantra and SSi MantrAsana tele-surgeon console in live demonstrations. The remote procedures performed or broadcast live at the event included: a right partial nephrectomy, a right hemicolectomy, a left-sided pyeloplasty on a pediatric patient, and a modified radical hysterectomy with a sentinel lymph node biopsy. Organized by the Society of Robotic Surgery and officially inaugurated by Dr. Jitendra Singh, India’s Minister of Science and Technology, the SRS India Conference convenes leading surgeons, delegates, researchers and industry partners in New Delhi each year. For video highlights of the telesurgeries showcased at the SRS India Conference, please visit: link.
Dr. Srivastava commented, “We were grateful for the opportunity to demonstrate the advanced telesurgery capabilities of our SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console this month at the 40th EACTS Annual Meeting in Barcelona and the inaugural SRS India Conference in New Delhi. As a pioneer and leader in telesurgery technology, SS Innovations aims to dismantle traditional geographic barriers and democratize access to world class health care.”
The SSi MantrAsana has been engineered for real-time remote procedures through ultra-low latency connectivity, high-definition visualization, and precise instrument control.
As of October 23, 2026, a total of 205 telesurgeries, including intricate cardiac procedures, have been performed with the SSi Mantra surgical robotic system.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana tele-surgeon console is a portable, compact alternative to the SSi Mantra’s standard surgeon command center that is intended to provide equivalent control functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments for the pediatric population and ENT surgeries. A vision cart is designed to provide the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 190 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kalle.ahl@theequitygroup.com
Devin Sullivan, Managing Director
T: (212) 836-9608
devin.sullivan@theequitygroup.com
Media Contact:
RooneyPartners LLC
Kate Barrette
T: (212) 223-0561
kbarrette@rooneypartners.com